Oct 24 (Reuters) - Medical device maker Baxter (BAX.N), opens new tab said on Thursday it expects to restart the highest-throughput intravenous solutions manufacturing line at a hurricane-hit plant in ...

Baxter expects to meet 90% to 100% of customer demand by the end of the year as the facility recovers in phases. North Cove is Baxter's largest facility, and it manufactures ~60% of IV fluids and ...

HOUSTON — Since Hurricane Helene made landfall in late September, along the southeastern shore, hospitals across the U.S. have had to adapt to a shortage of IV fluids. The plant that made 60 percent ...

NORTH CAROLINA, USA — The Biden administration says it has invoked the wartime powers of the Defense Production Act to speed rebuilding of a major American factory of intravenous fluids that was ...

Baxter International started to import IV fluids last week from two of its international manufacturing facilities to address supply shortages in the U.S. In coordination with HHS, the FDA and the ...

Surgery was Katie Adase's best chance at finally getting a diagnosis for the chronic pelvic pain that has been plaguing her for years. "I couldn't do laundry or walk to the grocery store or even cook ...

The United States is facing a significant shortage of intravenous (IV) fluids, including saline and dextrose solutions, exacerbated by damage to Baxter International (NYSE:BAX) plants in North ...

Alaska’s healthcare facilities are conserving use of intravenous or IV fluids as part of a statewide response to supply shortages. Hurricane Helene halted production at Baxter International, the ...